doi:10.3390/nu2030299 de Jager J, et al
A phase 2 randomized trial of survodutide in MASH and fibrosis
Immune Impact: The study also showed that semaglutide helps "reset" the liver's immune environment, restoring healthy T cell and B cell populations that are usually depleted by high-fat diets
When used for NASH, dual agonists decrease hepatic fat levels, enhance insulin sensitivity, and combat hepatic pathological complications (Monfeuga et al., 2024)
Most individuals begin noticing the difference in: 3 to 6 weeks Visible signs include: More radiance Reduced tan Smoother texture Lightened dark spots Even skin tone After completing all sessions, the skin continues to improve over the next few months
Polymorphisms in clock genes can modify cellular sensitivity to oxidative stress or genotoxic insults